Publication

Activation of thyroid hormone receptor-β improved disease activity and metabolism independent of body weight in a mouse model of non-alcoholic steatohepatitis and fibrosis

British Journal of Pharmacology 178(12):2412-2423, 2021

Kannt A, Wohlfart P, Madsen AN, Veidal SS, Feigh M, Schmoll D

Share this page

Resource Library

Related resources

Characterization of semaglutide treatment in the non-obese CDAA-HFD mouse model of advanced NASH with progressive fibrosis

Resolution of NASH and hepatic fibrosis by the GLP-1R and GCGR dual-agonist cotadutide via modulating mitochondrial function and lipogenesis

New insights into disease progression and human translatability of the GAN DIO-NASH mouse

Characterization of prophylactic lanifibranor treatment in the non-obese CDAA-HFD mouse model of advanced NASH with progressive fibrosis

For further information

Contact us

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm
Denmark

+45 3152 2650